Translations:Nicotine therapeutic benefits/192/en

From Safer nicotine wiki
Jump to navigation Jump to search
  • Animal Study
  • Due to the proven therapeutic effect of nicotine on AD (Alzheimer’s Disease) and PD (Parkinson’s Disease), we decided to study the role of nicotine in EAE as an animal model of MS. Our treatment group showed less inflammation in histopathological evaluation along with myelin sheet protection. Moreover, prevention group showed less inflammation compared with treatment group. Thus, nicotine might be recommended as a promising drug for MS therapy.
  • PDF Version
  • Citation: Naddafi F, Reza Haidari M, Azizi G, Sedaghat R, Mirshafiey A. Novel therapeutic approach by nicotine in experimental model of multiple sclerosis. Innov Clin Neurosci. 2013 Apr;10(4):20-5. PMID: 23696955; PMCID: PMC3659034.
Retrieved from "https://safernicotine.wiki/mediawiki/index.php?title=Translations:Nicotine_therapeutic_benefits/192/en&oldid=10615"